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tween resident renal cells and monocytes/macrophages is there-Expression of the chemokines MCP-1/CCL2 and RANTES/
fore likely to boost the number of infiltrating inflammatory cells.CCL5 is differentially regulated by infiltrating inflammatory cells.
Background. Chemokines are involved in the regulation of
the cellular renal infiltrate in glomerulonephritis; however, it is
unclear to which degree resident glomerular cells or infiltrating One of the hallmarks of early lesions in glomerular
leukocytes contribute to the formation of chemokines in glo- inflammation is infiltrating bone marrow-derived cells.merular inflammatory lesions. We therefore examined whether
Prominent cell types present in glomeruli are monocytes/monocytes/macrophages play a role in the expression of the
macrophages. Several well-defined mechanisms contrib-C-C chemokines MCP-1/CCL2 and RANTES/CCL5 in renal
tissue in a lipopolysaccharide (LPS)-induced model of inflam- ute to the monocyte attachment and infiltration into the
mation, where previously we have shown increased glomerular glomerulus [1–3], and recently much interest has focused
RANTES expression and glomerular infiltration of ED-1-posi- on the role that chemokines might play [4, 5]. In different
tive cells.
models of glomerular injury chemokines are expressedMethods. Inflammatory lesions were induced by an intra-
and secreted after the induction of the disease [6]. Moreperitoneal injection of LPS. The infiltration of monocytes into
the glomerulus was reduced by two experimental approaches. convincingly, it has been demonstrated that if the biologi-
First, rats were depleted of monocytes by the use of specific cal effects of chemokines were inhibited by the use of
monocyte-antisera or by cytotoxic drugs. Second, the infiltra- chemokine antisera or chemokine receptor blockers, the
tion of monocytes into the kidney was reduced by using inter-
influx of monocytes into the glomerulus is reduced [7–10].cellular adhesion molecule-1 (ICAM-1) knockout mice.
The role of monocytes in the regulation of glomerularResults. Both experimental approaches demonstrated a sig-
nificant reduction in the number of infiltrating monocytes/mac- chemokine formation in vivo is currently unknown. This
rophages after lipopolysaccharide injection. This reduction in the seems to be of major interest since inflammatory cell-
infiltration of inflammatory cells was associated with significantly derived chemokines could contribute to the amplifica-
reduced RANTES/CCL5 mRNA expression. However, MCP-1/
tion or potential resolution of the inflammatory processCCL2 mRNA expression was not inhibited after the LPS injec-
[11–13]. Increasing evidence shows that the interactiontion by monocyte/macrophage depletion. Also, the increase in
nuclear factor-B (NF-B) binding activity after the LPS in- between monocytes and resident tissue cells or other
jection was not reduced in pretreated animals. The experiments inflammatory cells is important in the regulation of che-
therefore demonstrate that infiltrating monocytes/macrophages mokine expression and secretion [14]. The mechanisms
contribute to increased RANTES/CCL5 mRNA expression in
in this network have been partially elucidated in in vitroinflammatory renal lesions, whereas MCP-1/CCL2 mRNA ex-
experiments and demonstrate, for example, that mono-pression and NF-B activation were not reduced by monocyte/
macrophage depletion. cyte chemoattractant protein-1 (MCP-1)/CCL2 secretion
Conclusion. MCP-1/CCL2 released from renal tissue upon is increased when monocytes are stimulated by two sig-
stimulation plays a major role in the regulation of monocyte/ nals, one from the attachment to P-selectins and themacrophage infiltration, which contributes significantly to in-
other from stimulated platelets [15, 16].creased renal RANTES/CCL5 expression. This cross-talk be-
The present experiments were designed to elucidate
possible in vivo interactions between glomerular cells and
1 Drs. Haberstroh and Pocock contributed equally to this work.
infiltrating monocytes with respect to regulated upon acti-
vation, normal T cell expressed and secreted (RANTES)/Key words: glomerular inflammation, lipopolysaccharide, adhesion
molecules, cell cross talk, monocyte chemoattractant peptide-1. CCL5 and MCP-1/CCL2 mRNA expression in a model
of LPS-induced glomerular inflammation [17]. 2002 by the International Society of Nephrology
1264
Haberstroh et al: MCP-1/CCL2 and RANTES/CCL5 expression 1265
METHODS In vitro incubation of renal tissue
Kidneys of non-treated ICAM-1 knockout and wild-Induction of renal inflammation
type mice were harvested and further processed underLPS model. Lipopolysaccharide (LPS, Escherichia coli
a laminar flow for sterile conditions. Renal cortex wastype O111:B4; Sigma, Munich, Germany) was injected
isolated by scissors and homogenized in a douncer. Corti-intraperitoneally (IP) in male Wistar rats (200 to 250 g
cal tissue single cell preparations were then cultured inbody weight; Charles River Wiga, Germany). The dose
RPMI supplemented with 10% fetal calf serum (FCS)used was 2 mg LPS/kg body weight.
and penicillin/streptomycin for 24 hours without stimula-Additional experiments were performed with intracel-
tion or stimulated with 1 g, 10 g/mL LPS or with 10
lular adhesion moleule (ICAM-1) knockout or wild-type
g LPS  100 IU interferon- (IFN-)/mL medium.
mice in which LPS was injected IP at a dose of 5 mg Thereafter, RNA was extracted for Northern blotting.
LPS/kg body weight. ICAM-1/ mice (129Sv/J1 back-
ground backcrossed to Balb/c for seven generations) and RNA isolation and Northern blot analysis
ICAM-1/ controls were maintained and bred in spe- Glomeruli from freshly harvested rat kidneys were
cific-pathogen-free (SPF) conditions, and were used for isolated by a sieving technique as described before [17].
experiments at the age of 12 to 16 weeks. Their care was In mice, cortex was isolated from kidneys and homoge-
in accordance with institutional guidelines. The generation nized in a douncer.
and characterization of the ICAM-1 knockout mice has Total RNA from isolated glomeruli of rats or from
been described in detail previously [18, 19]. kidneys of mice was extracted by phenol-chloroform
For control experiments, phosphate-buffered saline after direct lysis of glomeruli or kidney tissue in 4 mol/L
(PBS) was injected IP and animals were left untreated guanidinium thiocyanate, 25 mmol/L sodium citrate, pH
or treated with normal rabbit IgG or an irrelevant antise- 7, 0.5% sarcosyl, 0.1 mol/L 2-mercaptoethanol. Twenty
rum (a-J) intravenously (IV; as a control for monocyte/ micrograms of total RNA was electrophoresed through
macrophage antiserum) at the same time intervals. a 1.2% agarose gel in running buffer [2.2 mol/L formalde-
Thy-1.1 nephritis model. Mesangial cell proliferative hyde, 0.02 mol/L 3-(N-morpholino)-propanesulfonic acid,
glomerulonephritis was induced by an IV injection of a and 1 mmol/L ethylenediaminetetraacetic acid (EDTA)].
The RNA was transferred onto nylon membranes (Hy-rabbit anti-rat thymocyte antiserum. Technical aspects of
bond-N; Amersham Bioscience) and after UV-crosslink-the procedure and characteristics of this nephritis model
ing prehybridized at 65C for one hour in 0.1  standardhave been described in detail previously [20, 21].
sodium citrate (SSC; 20 SSC 3 mol/L NaCl, 0.3 mol/L
sodium citrate), 0.5% sodium dodecyl sulfate (SDS). TheMonocyte/macrophage depletion
cDNA probe used were the following: MCP-1/CCL2 (aA monocyte/macrophage antiserum was prepared as
577 bp Eco-R1 fragment), RANTES/CCL5 (an EcoRI-described previously [22]. In brief, proteose peptone
XhoI fragment of the murine RANTES clone pMuR3)(10%)-stimulated peritoneal rat macrophages were har-
and a 2.0 kb insert of pMCI encoding the murine 18 Svested and rabbits immunized four times. The IgG frac-
RNA band as decribed previously [17, 20, 21]. The cDNAtion of the rabbit antiserum was prepared after heat
fragments were labeled with 50 Ci [	-32P]dCTP (3000inactivation of the serum (56C, 1 h) by ammonium sul-
Ci/mmol; Amersham Bioscience) using a random prim-
fate precipitation. The antiserum used was from a single
ing kit (Oncor Appligene, Heidelberg, Germany). The
pool and tested for efficiency by monocyte depletion in membranes were hybridized with 106 cpm probe per mL
peripheral blood smears prior to its use in experiments. in Rapid-Hyb buffer (Amersham Bioscience) for 24
The antiserum was injected at minus 12 hours and at hours at 70C using a rotating drum. After hybridization
minus one hour before the LPS injection. blots were washed for 20 minutes in 2  SSC (20  SSC:
In additional experiments, a specific, adsorbed, rabbit 3 mol/L NaCl, 0.3 mol/L sodium citrate, pH 7.0), and
anti-rat macrophage antiserum was used (Accurate Chem- 0.1% SDS at room temperature, for at least 15 minutes
ical, Westbury, NY, USA) [23]. The antiserum was in- in 0.4 SSC in 0.1% SDS at 65C and autoradiographed.
jected at minus two days and at minus one hour before Membranes were stripped with 5 mmol/L Tris-HCl, 0.2
the LPS injection. mmol/L EDTA, 0.5% sodium pyrophosphate, and 5 
Additional rats were pretreated with nitrogen mustard Denhardt’s solution for 30 minutes at 65C, and were
(NM; 0.5 mg/kg body weight) once IV two days prior to subsequently rehybridized with the cDNA probe for the
LPS injection or cyclophosphamide (CyP) was adminis- 18 S band to account for small loading and transfer varia-
tered IP at 70 mg/kg body weight on day minus 5 and tions. Exposed films were scanned with the Fluor-STM
at 35 mg/kg body weight at day minus 2 prior to the LPS MultiImager and analyzed with the computer program
‘Multianalyst’ 1.1 or the hybridized membranes wereapplication [24, 25].
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subjected to the GS-363 Molecular Imager System and g/mL leupeptin] and rocked at 400 rpm on ice on a
shaking platform for 15 minutes. After centrifugation at‘Molecular Analyst’ 1.5 (Bio-Rad Laboratories, Munich,
Germany). Relative changes in RNA were calculated 15,000  g for five minutes the nuclear extracts were
stored in aliquots at 80C. Protein concentration wasafter assigning hybridization in control lanes a relative
value of one. Samples were normalized for the signal measured using the DC protein assay reagent (Bio-Rad
Laboratories).intensity of the 18 S ribosomal RNA hybridization. De-
tails of this procedure have been published previously A nuclear factor-B (NF-B) consensus oligonucleo-
tide probe (5
-AGT TGA GGG GAC TTT CCC AGG[20, 21, 26].
C-3
; Promega, Heidelberg, Germany) was end-labeled
Western blot analysis with [-32P]ATP (3000 Ci/mmol; Amersham Bioscience).
One to 5 g of nuclear protein was incubated for 30Isolated glomeruli of kidneys were lysed in 100 L
Laemmli-buffer. Protein concentration was determined minutes at room temperature with 100,000 cpm of the
probe in 20 mmol/L HEPES (pH 7.9), 0.3 mmol/Lwith the DC protein assay reagent (Bio-Rad Laboratories).
One hundred micrograms of protein were loaded onto a EDTA, 0.2 mmol/L EGTA, 80 mmol/L NaCl and 2 g
Poly(dI-dC)Poly(dI-dC) (Amersham Bioscience) in a to-12.5% SDS-PAGE and semi-dry blotted onto a polyvinyl-
idene difluoride (PVDF)-membrane (Hybond-P; Amer- tal volume of 20 L. The DNA-protein complexes were
subjected to electrophoresis on a 4% polyacrylamide gelsham Bioscience). The blots were blocked in 5% non-fat
dry milk in PBS and 0.1% Tween-20 before incubating that contains 2.5% glycerol, 6.7 mmol/L Tris-HCl (pH
7.5), 3.3 mmol/L sodium acetate and 0.1 mmol/L EDTA.the blots for one hour in a 1:1000 dilution of the antibodies
against ICAM-1 (R & D Systems, Wiesbaden, Germany) After electrophoresis for 2.5 hours at 15C the gel was
vacuum-dried and autoradiographed.or PCNA (Transduction Laboratories, Heidelberg. Ger-
many). After washes in PBS and 0.1% Tween-20, the
Southwestern histochemistryblots were incubated for another hour in a 1:2000 dilution
of rabbit anti-goat- or goat anti-mouse-horseradish per- The Southwestern histochemistry was performed as
described in detail previously [28]. NF-B consensusoxidase-linked IgG (Southern Biotechnology Associates,
Birmingham, AL, USA) as the secondary antibody. The oligonucleotides were digoxigenin labeled with a 3
-ter-
minal transferase (Roche, Mannheim, Germany). Paraf-antibody-labeled proteins were detected with enhanced
chemiluminescence (ECL) according to the manufactur- fin-embedded tissue sections were fixed in 0.5% para-
formaldehyde and incubated with 0.1 mg/mL DNase I.er’s description (Amersham Bioscience). Exposed films
were scanned with the Fluor-STM MultiImager and ana- The DNA-binding reaction was performed by incubation
with 10 pmol of the labeled DNA probe in buffer contain-lyzed with the computer program “Multianalyst” 1.1
(Bio-Rad Laboratories). Details of this technique have ing 0.25% bovine serum albumin (BSA) and 0.5 g/mL
poly(dI-dC). The sections were then incubated with alka-been published previously [20, 21].
line phosphatase-conjugated anti-dioxigenin antibody
Glomerular nuclear mini-extracts and EMSA and colorimetric detection was performed. Preparations
without probe were used as negative controls, and mu-Kidneys were perfused with 150 mL sterile PBS per
animal before harvesting. The nuclear mini-extracts were tant-labeled probe and excess of unlabeled probe were
used to test the specificity of the technique.prepared and the electrophoretic mobility shift assay
(EMSA) run according to the procedure described by
MorphologySakurai et al [27] with minor modifications. Briefly, iso-
lated glomeruli from two animals were resuspended in Kidney samples were fixed in 4% buffered formalin
and embedded in paraffin. For light microscopy 4-m400L buffer A [10 mmol/L HEPES (pH 7.9), 10 mmol/L
KCl, 0.1 mmol/L EDTA, 0.1 mmol/L ethylenaglycol-bis thick sections were stained with periodic acid-Schiff
(PAS). Immunohistochemistry was performed with ED-1(-amino ether)-N,N
-tetraacetic acid (EGTA), 1 mmol/L
dithiothreithol (DTT) and 0.5 mM phenylmethyl-sulfo- antibody (Chemicon, CA, USA) for rats and F4/80 or
MCA519 antibodies (Serotec, Mu¨nchen, Germany) fornylfluoride (PMSF), 10 g/mL aprotinin, 10 g/mL leu-
peptin], homogenized with 50 strokes in a 7 mL glass- mice to determine kidney infiltrating monocytes/macro-
phages. Alkaline phosphatase-antialkaline phosphatasehomogenizer (Wheaton, IL, USA) and chilled on ice for
15 minutes. After adding 25 L of 10% Nonidet P-40 the (APPAP; Camon, Wiesbaden, Germany) was used as the
detection system. Technical details of the morphologicalhomogenate was vigorously vortexed for 10 seconds and
centrifuged at 15,000  g for five minutes. To extract the procedures have been outlined previously [20, 26]. To
count the number of infiltrating monocytes/macrophagesnuclear proteins the nuclear pellet was resuspended in
100L buffer B [20 mmol/L HEPES (pH 7.9), 0.4 mmol/L per glomerular cross sectional area, at least 30 glomeruli
were evaluated from each kidney in a blinded fashion.NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L
DTT and 1 mmol/L PMSF, 10 g/mL aprotinin, 10 The amount of monocyte/macrophage infiltration into
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Table 1. Efficiency of monocyte/macrophage depletionthe tubulointerstitium of the kidney was determined by
in rat experiments
counting the number of positively stained cells per 20
ED1-positive cells/visual fields (magnification 720).
Peripheral blood glomerular cross
monocytes/nl sectional areaExperimental design
Control 490120 0.22.1
Rat experiments. The following groups of animals LPS 610175 4.51.8a
LPS  a-M/M 8045c 1.01.5bwere examined:
LPS  NM 3522c 0.31.8c
LPS  CyP 2215c ND
(1) Untreated. LPS or for controls PBS was injected LPS  a-RM 1811c ND
intraperitoneally. To demonstrate for efficiency of the pretreatment protocols used in rats to
deplete monocytes/macrophages peripheral blood monocytes and ED-1 positive(2) Pretreated with cytotoxic drugs. Additional animals
cells per glomerular cross-sectional area were counted in controls and 6 hourswere pretreated two days prior to LPS application after intraperitoneal LPS-injection (N 3). Animals were pretreated with rabbit
anti-rat monocyte/macrophage antisera (a-M/M or a-RM) or with cytotoxic drugswith nitrogen mustard intravenously or five and
(NM or CyP). Abbreviations are in the Appendix; ND is not done.two days prior to LPS injection with cyclophos- aP  0.05 vs. control
bP  0.05 and cP  0.01 when compared with LPS-injected otherwise non-phamide intraperitoneally.
pretreated rats(3) Pretreated with antisera. Another group of animals
was pretreated with rabbit anti rat monocyte/mac-
rophage antisera intravenously before LPS injec- Statistical analysis
tion. Controls were treated with IV injected nor- Results are expressed as means SEM. For statistical
mal rabbit serum. comparison the Mann-Whitney U test was performed.
For multiple group comparisons, the non-parametric
From controls and at 1, 3 and 6 hours after LPS injec- Kruskal-Wallis test was used. P values 0.05 were con-
tion, the kidneys were harvested and further processed sidered as statistically significant. For Northern blot anal-
for morphological examinations and glomerular isola- ysis an increase or decrease of RNA expression as deter-
tion of RNA, for glomerular cytoplasmic protein extrac- mined by densitometry of at least 25% was considered
tion or for glomerular preparation of nuclear proteins. significant (P  0.05) and analyzed further with the
Two rats were used for morphology, for glomerular Kruskal-Wallis test.
RNA extraction three rats, glomerular cytoplasmic pro-
tein extraction two rats, and for glomerular nuclear pro-
RESULTStein preparation two rats were examined. The experi-
Monocyte/macrophage depletionments were repeated two to three times.
Mouse experiments. The following groups of animals To test for efficiency of monocyte/macrophage deple-
were examined: tion using rabbit anti-rat monocyte/macrophage antisera
or cytotoxic drugs differential peripheral blood cell
(1) In vivo experiments. LPS or for controls PBS was counts for monocytes were performed in control rats
injected intraperitoneally in either ICAM-1 wild- and rats six hours after the injection of LPS (Table 1).
type or knockout mice. For morphology kidneys In the same animals the number of ED-1-positive cells
of two mice were examined from controls and 3, per glomerular cross sectional area also was determined
6, 12 and 24 hours after an IP LPS-injection in (Table 1). To exclude non-specific side effects of either
wild-type and knockout animals. At 12 and 24 the monocyte/macrophage antiserum or of the cytotoxic
hours after the LPS application kidneys were har- drug, two different monocyte/macrophage antisera were
vested from additional ICAM-1 wild-type and used, one produced in our in-house animal facilities
knockout mice (N  3) and the cortex homoge- (monocyte/macrophage antiserum) and one commercially
nized for RNA extraction. A pool of kidneys taken available (a-RM); two different cytotocix drugs (nitrogen
from 2 to 3 animals was examined and experiments mustard and cyclophosphamide) also were used.
were repeated three times. As shown in Table 1, the number of circulating periph-
(2) Ex vivo experiments. Additional in vitro experi- eral monocytes was significantly reduced (P  0.01) six
ments were performed. For this purpose kidneys hours after LPS injection in animals pretreated with ei-
(N  2 animals) were harvested under sterile con- ther the antisera or the cytotoxic drugs. Also, the number
ditions and single cell suspensions prepared from of monocytes/macrophages infiltrating the glomerulus
cortex both from ICAM-1 wild-type and knockout was significantly reduced (P at least0.05) in pretreated
animals. Single cell suspensions were incubated in animals at six hours after LPS injection. Our prior study
vitro with or without further stimulation with LPS demonstrated the maximum of inflammatory cell infil-
or LPS and IFN- for 24 hours before RNA ex- tration into the glomerulus after LPS-application at this
time point [17].traction. The experiments were repeated twice.
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Fig. 1. Glomerular RANTES/CCL5 mRNA expression. Rats pre-
treated or non-pretreated for monocyte/macrophage depletion (N 
3) were injected intraperitoneally with lipopolysaccharide (LPS). Glo-
merular RANTES/CCL5 mRNA expression was determined at time
intervals after LPS injection. (A ) Expression 6 hours after LPS-injec-
tion in animals not-pretreated (PBS) or pretreated with a rabbit anti-
rat monocyte/macrophage antiserum (a-M/M), an irrelevant rabbit
antiserum (a-J) or nitrogen mustard (NM). (B ) Expression at 1, 3 and
6 hours after LPS-injection in rats pretreated or not with cyclophospha-
mide (CyP). (C ) Expression at 1, 3 and 6 hours after LPS-injection in
rats pretreated or not with a rabbit anti-rat monocyte/macrophage
antiserum (a-RM). The figures are representative of two independent
complete sets of experiments. Significance values are: *P  0.05 when
compared with controls; #P 0.05 when compared with non-pretreated
animals after LPS-injection.
Glomerular RANTES/CCL5 mRNA expression Glomerular MCP-1/CCL2 mRNA expression
MCP-1/CCL2 mRNA expression was already increasedGlomerular RANTES/CCL5 mRNA expression in-
creased rather late after LPS injection, with a maximum at one hour after LPS injection and was consistently
elevated throughout the six-hour observation periodat six hours when compared with control rats (Fig. 1 A, B).
When animals were pretreated to deplete mono- when compared with controls (Fig. 2 A, B).
Pretreating animals for monocyte/macrophage deple-cytes/macrophages before LPS injection, the glomeru-
lar RANTES/CCL5 mRNA expression was significantly tion with either cyclophosphamide (Fig. 2A) or with a
specific antiserum (Fig. 2B) did not reduce glomerularreduced when compared with non-pretreated rats after
LPS injection. This was shown by the use of cytotoxic drugs MCP-1/CCL2 mRNA expression. We found a slight, al-
beit not consistent increase of glomerular MCP-1/CCL2and monocytes/macrophage antisera. Nitrogen mustard
(Fig. 1A) and cyclophosphamide (Fig. 1B) significantly expression at one hour after LPS-injection in cyclophos-
phamide pretreated rats when compared with non-pre-reduced glomerular RANTES/CCL5 mRNA expression
at three and six hours after LPS-injection. Also, the rab- treated animals (Fig. 2A). At three and six hours after
LPS-application, the MCP-1/CCL2 expression was notbit anti-rat monocyte/macrophage antisera used signifi-
cantly reduced glomerular RANTES/CCL5 mRNA expres- different in cyclophosphamide-pretreated animals when
compared with non-pretreated rats (Fig. 2A). Also, asion (Fig. 1 A, C). This effect was specific for monocyte/
macrophage depleting antisera, as an irrelevant antise- rabbit anti-rat monocyte/macrophage antiserum did not
reduce glomerular MCP-1/CCL2 mRNA expression atrum (a-J) did not significantly influence glomerular
RANTES/CCL5 expression (Fig. 1A). three and six hours after LPS-injection (Fig. 2B).
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Fig. 2. Glomerular MCP-1/CCL2 mRNA expression. In rats pre-
treated or non-pretreated for monocyte/macrophage depletion (N 
3) glomerular MCP-1/CCL2 mRNA expression was determined. (A )
Expression at 1, 3 and 6 hours after LPS-injection in rats pretreated
or not with cyclophosphamide (CyP). (B ) Expression at 1, 3 and 6
hours after LPS-injection in rats pretreated or not with a rabbit anti-
rat monocyte/macrophage antiserum (a-RM). (C ) Expression at 24
hours and 5 days after the induction of anti-Thy 1.1-nephritis in rats
pretreated or not with cyclophosphamide (CyP). The figures are repre-
sentative of two independent complete sets of experiments. Significance
values are: *P  0.05 when compared with controls; #P  0.05 when
compared with non-pretreated animals.
In order to test whether these findings are generaliz- or the proliferation marker PCNA, glomerular protein
expression was determined at six hours after LPS injec-able for other inducers of glomerular injury that are
more specifically targeted for the kidney, the Thy-1.1 tion in pretreated and non-pretreated rats.
Glomerular ICAM-1 protein expression is signifi-nephritis model was used. There was a significant in-
crease in glomerular MCP-1/CCL2 mRNA expression cantly increased at six hours after LPS injection when
compared with control rats (P 0.01). This increase wasat 24 hours after the IV injection of the anti-Thy-1.1
antibody, as also described previously (Fig. 2C) [20, 21]. not reduced in animals pretreated with the rabbit anti-rat
monocyte/macrophage antiserum or nitrogen mustardDepleting animals of monocytes/macrophages by cyclo-
phosphamide administration before the induction of the (NM) (Fig. 3).
As a marker of glomerular proliferation PCNA pro-Thy-1.1 nephritis did not reduce, but rather significantly
increased glomerular MCP-1/CCL2 expression at 24 tein expression was determined by Western blotting.
PCNA protein was significantly increased at six hourshours when compared with non-pretreated nephritic rats
(Fig. 2C). after LPS injection when compared with control rats
(P  0.01). This LPS-induced increase in glomerular
Glomerular ICAM-1 and PCNA expression proliferation was not changed in monocyte-depleted ani-
mals using a rabbit anti-rat monocyte/macrophage anti-To determine whether the interventional treatment
of the animals for monocyte/macrophage depletion also serum (Fig. 3). With NM the glomerular PCNA protein
expression was, however, significantly reduced at six hourschanged the expression of the adhesion molecule ICAM-1
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cant increase in glomerular NF-B expression three hours
after LPS injection when compared with controls. By
double staining with the monocyte-specific antiserum
ED-1, NF-B activation could be detected both in resi-
dent glomerular cells and infiltrating monocytes/macro-
phages (Fig. 5).
Experiments in ICAM-1 knockout mice
To further examine the role that inflammatory infil-
trating cells might play in renal RANTES/CCL5 mRNA
Fig. 3. Glomerular intracellular adhesion molecule-1 (ICAM-1) and
expression, ICAM-1 knockout mice were used. It hasproliferating cell nuclear antigen (PCNA) protein expression. In rats
pretreated or non-pretreated for monocyte/macrophage depletion been shown previously that the number of infiltrating
(N  2) glomerular protein expression was determined by Western inflammatory cells is significantly reduced in ICAM-1blotting. Expression was determined at 6 hours after LPS injection
knockout animals after the induction of inflammatoryin animals not-pretreated (PBS) or pretreated with a rabbit anti-rat
monocyte/macrophage antiserum (a-M/M), an irrelevant rabbit antise- lesions [18, 19, 30].
rum (a-J) or nitrogen mustard (NM). The figure is representative of
We first reproduced these findings in our model ofthree independent complete sets of experiments.
LPS-induced renal inflammation by morphological ex-
aminations. Monocytes/macrophages stained positive with
F4/80 or MCA519 antibodies (Serotec, Wiesbaden, Ger-
after LPS injection when compared with non-pretreated many) in glomeruli and tubulointerstitium after LPS in-
animals (P  0.05). This indicates that NM not only jection, as shown at six hours (Fig. 6A). Counting cells
reduced the proliferation of bone marrow derived cells, at 3, 6, 12 and 24 hours after LPS injection demonstrated
but also reduced the proliferation of glomerular cells. a significant reduction of the number of infiltrating
monocytes/macrophages in glomeruli and interstitum inEffect of monocyte/macrophage depletion on
ICAM-1 knockout mice when compared with wild-typeglomerular NF-B activation
animals (Fig. 6B).
The activation of transcription factors plays a pivotal The mRNA expression of renal RANTES/CCL5 then
role for the regulation of chemokine expression. As shown was determined in mice. As shown for the experiments
by others in in vitro and in vivo studies, the activation in rats, reducing the number of infiltrating mononuclear
of the transcription factor nuclear factor-B (NF-B) cells into the kidney was associated with a reduced
plays a major role in the regulation of MCP-1/CCL2 RANTES/CCL5 mRNA expression. A significant reduc-
and RANTES/CCL5 expression [29]. Therefore, to fur-
tion of RANTES/CCL5 expression in ICAM-1 knockout
ther elucidate possible mechanisms by which glomerular
mice was found when compared with wild-type animals
RANTES mRNA expression might be reduced by
at 12 and 24 hours after LPS injection, as shown in Fig-monocyte/macrophage depletion, the activation of the
ure 7.transcription factor NF-B was examined.
To exclude the possibility that renal tissue fromGlomerular NF-B DNA binding activity significantly
ICAM-1 knockout animals is less responsive to LPS thanincreased at one, three and six hours after LPS-injection
renal parenchymal cells taken from ICAM-1 wild-typewhen compared with controls with a maximum at three
animals, kidneys from both knockout and wild type ani-hours (Fig. 4). Pretreating rats for monocyte/macrophage
mals were isolated, single cell suspensions prepared, anddepletion with NM (Fig. 4A; lane 3 vs. lane 2) or cyclo-
these cells incubated in vitro with LPS and LPS IFN-.phosphamide (CyP; Fig. 4B) did not significantly reduce
The experiments demonstrated a significant increase inglomerular NF-B DNA binding activity. With the use
RANTES/CCL5 mRNA expression in renal parenchy-of rabbit anti-rat monocyte/macrophage antisera there
mal cells taken from ICAM-1 wild-type and knockoutwas a trend, albeit not significant, to an even enhanced
animals when compared with cell populations beforeglomerular NF-B DNA binding activity at all time
LPS was added to the medium. There was no significantpoints examined after LPS injection (Fig. 4C).
difference in RANTES/CCL5 expression when singleIn addition to gel shift experiments, the activation of
cell suspension taken from wild-type animals was com-the transcription factor NF-B was analyzed in situ by
pared with knockout mice (Fig. 8). These results are inSouthwestern histochemistry in paraffin embedded tis-
accordance with other studies demonstrating that circu-sue sections to further evaluate which glomerular cell
lating mononuclear cells of ICAM-1 knockout mice re-population, resident cells or infiltrating inflammatory
spond similarly to cells taken from ICAM-1 wild-typecells contribute to increased NF-B binding activity after
LPS injection. As shown in Figure 5, there was a signifi- animals to an inflammatory stimulus [31, 32].
Fig. 4. Glomerular nuclear factor-B (NF-B) DNA binding activity.
In rats pretreated or non-pretreated for monocyte/macrophage deple-
tion (N  2) glomerular nuclear proteins were isolated from controls
and after LPS was injected intraperitoneally and NF-B consensus
DNA binding activity determined by gel shift experiments (EMSA).
(A ) NF-B binding activity at 6 hours after LPS (lane 2) when com-
pared with control animals (lane 1; P  0.05) and rats pretreated with
nitrogen mustard (lane 3) or anti-monocyte/macrophage antiserum
(lane 4). (B ) EMSA in rats non-pretreated (lanes 1-4) or pretreated
with cyclophosphamide (CyP) (lanes 5-8) in controls (lanes 1 and 5)
and after LPS-injection. (C ) NF-B binding activity in non-pretreated
(lanes 1-4) or animals pretreated with anti monocyte/macrophage anti-
serum (a-RM) (lanes 5-8) in controls (lanes 1 and 5) and after LPS
injection. The figures are representative of two independent complete
sets of experiments.
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Fig. 6. Staining for monocytes/macrophages in
LPS-treated mice. Renal tissue from ICAM-1
wild type and ICAM-1 knockout mice (N 2)
was stained for MCA519-positive monocytes/
macrophages in controls and 3, 6, 12 and 24
hours after LPS injection. (A ) Representative
sections are given for glomeruli and tubulo-
interstitium at 6 hours after LPS injection.
(Reproduction of this figure in color was made
possible by a grant from Aventis Pharma, Bad
Soden, Germany.)
DISCUSSION
Chemokines play a pivotal role in directing migration
and adhesion of infiltrating cells to an inflammatory le-
sion. Inhibition of chemokine expression or secretion
significantly reduced cell infiltration and injury. These
mechanisms also apply for renal diseases. Abolishing
the effect of chemokines by the use of specific antisera
reduced the number of cells infiltrating the glomerulus
in different models of glomerulonephritis [6, 9, 10, 33].
Chemokines are expressed and secreted upon stimula-
tion by resident tissue cells such as mesangial cells, and
also by inflammatory cells such as monocytes/macro-
phages. The release of chemokines from these cells also
is regulated by costimulatory mediators [5, 6, 11]. For
Fig. 5. Southwestern histochemistry for NF-B. In controls and rats 3
hours after LPS injection (N  2) NF-B binding was localized in the
glomeruli by Southwestern histochemistry. In additional experiments
double staining for ED1-positive monocytes/macrophages was per-
formed. Closed arrows indicate nuclear localization of NF-B, and open
arrows indicate cells that stained positive for NF-B and simultaneously
ED-1 (magnification 720). (Reproduction of this figure in color was
made possible by a grant from Aventis Pharma, Bad Soden, Germany.)
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Fig. 6. (Continued) (B ) Quantification of
MCA519-positive cells per glomerular cross
sectional and interstitial areas in time intervals
after LPS-injection. Symbols are: () ICAM-1
wild-type mice; () ICAM-1 knockout mice;
*P  0.05 when wild-type animals were com-
pared with ICAM-1 knockout mice.
example, MCP-1/CCL2 released from monocytes adher-
ent to the adhesion molecule P-selectin is further in-
creased by mediators released from activated platelets
[15, 16]. Cross-linking of ICAM-1 also induced interleu-
kin-8 (IL-8)/CXCL8 and RANTES/CCL5 expression in
human endothelial cells [34]. Thus, the amount of che-
mokines released at an inflammatory site depends on a
cross talk between infiltrating inflammatory and resident
tissue cells. This cross talk is likely to substantially influ-
ence the outcome of the lesion.
The present experiments thus focused on infiltrating
monocytes to investigate their potential role with respect
to glomerular MCP-1/CCL2 and RANTES/CCL5 mRNA
expression. Our results demonstrate that glomerular
RANTES/CCL5 mRNA expression depends on mono-
cytes infiltrating the glomerulus. Depletion of monocytes
before the induction of the inflammatory lesion by LPS
significantly reduced glomerular RANTES/CCL5 expres-
sion (Fig. 1). This was seen with specific rat monocyte/
Fig. 7. Renal RANTES/CCL5 mRNA expression in ICAM-1 knockout
macrophage antisera and with cytotoxic drugs (nitrogen and wild-type mice. RNA was extracted from renal tissue of mice
(N  3) at 12 and 24 hours after LPS was injected intraperitoneally.mustard or cyclophosphamide). Glomerular inflamma-
This figure is representative of three independent complete sets oftory responses to LPS were, however, not unspecifically
experiments. Significance values are: *P at least 0.05 when compared
reduced by the treatment protocols. First, glomerular with controls; #P  0.05 when compared with wild-type animals after
LPS-injection.MCP-1/CCL2 mRNA expression significantly increased
at one hour after LPS injection and remained signifi-
cantly elevated throughout the six-hour observation pe-
riod (Fig. 2). This increased glomerular MCP-1/CCL2 by PCNA protein expression was not reduced by the
mRNA expression was not reduced by the treatment antiserum (Fig. 3). Nitrogen mustard reduced glomerular
protocols using either monocyte/macrophage antisera or PCNA expression, however, this might be due to non-
cytotoxic drugs for cell depletion. This is in accordance specific side effects of NM as it not only inhibits prolifera-
with previously published data in the zymosan peritonitis tion of bone marrow derived cells, but also might induce
model in mice demonstrating that macrophage depletion growth arrest of glomerular cells.
did not modify the amounts of MCP-1 released in the In an anti-GBM model of glomerulonephritis, Lef-
lavage fluid [35]. kowith and coworkers have previously demonstrated
Second, glomerular ICAM-1 expression was signifi- that the glomerular expression of CC and CXC chemo-
cantly increased six hours after LPS application and nei- kines is dependent on the presence of polymorphonu-
ther the monocyte/macrophage antiserum or NM re- clear leukocytes (PMN) and monocyte/macrophage. In
duced this increased expression, and also an increased the early phase of this model chemokine expression was
PMN dependent, and in the later or sustained phase ex-proliferative response after LPS injection as determined
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the tissue by increasing the local amount of chemokines
released.
Further support of this pathogenetic link comes from
the present experiments performed in ICAM-1 knockout
mice. In these animals the LPS-induced infiltration of
monocytes into the kidney was significantly reduced at all
time points examined (Fig. 6). The reduced number of
monocytes infiltrating the kidney parallels the significantly
reduced RANTES/CCL5 gene expression in ICAM-1
knockout animals when compared with wild-type mice
(Fig. 7). However, when incubating single cells taken
from kidney cortex homogenates in vitro with LPS or a
combination of LPS and IFN- for 24 hours, RANTES/
CCL5 gene expression was significantly increased when
compared with non-treated controls and there were no
significant differences between wild-type and knockout
mice (Fig. 8). These data demonstrate that resident renal
cells respond with a similar increase in RANTES gene
expression after in vitro stimulation. Thus, reduced
RANTES gene expression found in ICAM-1 knockoutFig. 8. RANTES/CCL5 mRNA expression in renal parenchymal cells
after in vitro LPS-stimulation. Renal parenchymal single cell suspen- mice in vivo strictly correlates with the reduced number
sions were prepared from ICAM-1 knockout and wild-type mice and
of infiltrating monocytes.stimulated in vitro for 24 hours with LPS or a combination of LPS and
Adhesion molecules and their ligand counterparts playIFN-. When compared with controls (lane 1) there was a significant
increase (P 0.01) in RANTES/CCL5 mRNA expression after stimula- an important role in the recruitment of cells to inflam-
tion with high doses of LPS or the combination of LPS and IFN-
matory lesions, in signal transduction and regulation of(lanes 3 and 4). The increase in RANTES/CCL5 expression at a low
chemokine expression [40, 41]. ICAM-1 knockout animalsLPS concentration in wild-type animals (lane 2) was not consistently
reproduced and might be due to some contamination during the single have been an exciting tool to investigate mechanisms of
cell preparation procedure. The figure is representative of two indepen-
inflammatory processes in in vivo experiments [19, 30,dent complete sets of experiments.
42–44]. A reduced inflammatory response and tissue in-
jury in the kidney has been described in ICAM-1 knock-
out animals, for example, when heterologous and auto-
pression of chemokines was monocyte/macrophage de- logous models of anti-GBM disease were examined. In
pendent [36]. These data together with the present find- these models improved glomerular morphology after the
ings demonstrate that glomerular chemokine expression induction of the disease strictly correlated with a reduced
involves a complex network of factors between resident number of infiltrating inflammatory cells. Also, in a model
and infiltrating inflammatory cells. This positive feed- of systemic autoimmune disease in the MRL/MpJ-Faslpr
back loop between glomerular cells and infiltrating in- mice, additional ICAM-1 deficiency resulted in a signifi-
flammatory cells further increases chemokine gene ex- cant reduction in vasculitis in the kidney through im-
pression and hence might boost the number of infiltrating paired neutrophil and/or T cell adhesion [45]. Treatment
inflammatory cells. These in vivo data are supported by with a monoclonal antibody to ICAM-1 also reduced
recently published in vitro data where in co-culture experi- proteinuria in a rat model of in situ immune complex
ments the interaction between monocytes and fibroblasts glomerulonephritis [46]. Recent experiments also dem-
or monocytes and astrocytes were shown to increase onstrate that cell-to-cell contact between T cells and re-
MCP-1/CCL2 production [37, 38]. Physically separating nal tubular epithelial cells mediated in part by LFA-1/
the two cell types by a semipermeable membrane pre- ICAM-1 interactions are involved in RANTES/CCL5
cluded MCP-1/CCL2 production. Thus, the interaction production, a pathogenic role of which has been pro-
of resident cells with infiltrating inflammatory cells by posed for interstitial mononuclear cell infiltration pre-
adhesion molecules and their ligands may coamplify che- viously [14, 47].
mokine production. It also has been demonstrated re- Chemokines are not stored at the cellular level. The
cently that RANTES/CCL5 released from platelets after regulation of chemokine expression is mostly due to a
stimulation binds to activated endothelial cells and en- new and rapid transcription, which is tightly regulated
hances the firm adhesion of monocytes to the endothe- upon binding of transcription factors to the promoter
lium [39]. These data together with the present findings regions. Therefore, to elucidate possible mechanisms by
support the pathophysiological concept that inflamma- which infiltrating glomerular cells might reduce glomeru-
lar RANTES/CCL5 gene expression, we examined thetory cells further boost the inflammatory response in
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(specific); CyP, cyclophosphamide; EMSA, electrophoretic mobilityactivation of the transcription factor NF-B in isolated
shift assay; GBM, glomerular basement membrane; ICAM-1, intracel-glomeruli taken from rats one, three and six hours after lular cell adhesion molecule-1; IL-8, interleukin-8; LPS, lipopolysaccha-
LPS-injection. RANTES/CCL5 and MCP-1/CCL2 mRNA ride; MCP-1, monocyte chemoattractant protein-1 (CCL2); M/M,
monocytes/macrophages; NF-B, nuclear factor-B; NM, nitrogenexpression are regulated by NF-B as shown previously
mustard; PCNA, proliferating cell nuclear antigen; PMN, polymorpho-by others [48, 49]. Systemic LPS induced NF-B activa- nuclear leukocytes; RANTES, regulated upon activation, normal T
tion in ex vivo isolated glomerular nuclear proteins (Fig. cell expressed and secreted (CCL5); SPF, specific-pathogen-free; Thy
1.1-nephritis, glomerulonephritis induced by intravenous injection of4). This NF-B activation was not reduced in animals
a rabbit anti-rat thymocyte antiserum.pretreated with a specific anti-monocyte antiserum or
cytotoxic drugs (cylclophosphamide). Thus, reducing the
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